Introduction
============

The *Drosophila melanogaster aurora A* gene was first identified through mutations resulting in either female sterility or maternal effect lethality. In both cases, mutations were associated with mitotic defects including failure for centrosomes to separate ([@bib12]). Subsequently, it was shown to encode a protein kinase that is widely present in eukaryotic genomes ([@bib9]). *Aurora A* is an essential gene in mammals and is expressed at elevated levels in a wide variety of tumor cells. Its overexpression is sufficient to trigger genetic instability and transformation in NIH3T3 mouse fibroblasts but not in normal cells, suggesting that this protein might behave as an oncogene under specific genetic backgrounds ([@bib11]; [@bib5]). The multiple roles of aurora A protein kinase in centrosome function and mitotic spindle assembly in *Drosophila*, *Caenorhabditis elegans*, *Xenopus laevis*, and human cells have been extensively studied ([@bib23]; [@bib16]; [@bib10]; [@bib1]). In many systems, the phenotypes caused by *aurora A* loss of function suggest that *aurora A* regulates the dynamics of astral microtubules. To do so, it has been shown that aurora A phosphorylates several microtubule-associated proteins, including the D-TACC subunit of the D-TACC--Msps microtubule-stabilizing complex. Indeed, after phosphorylation by aurora A, the D-TACC--Msps complex is targeted to the centrosome component, centrosomin. The Msps subunit of the complex (XMAP215 homologue) binds directly to microtubules to promote microtubule growth. It is thus proposed that phosphorylation of the D-TACC--Msps complex favors stabilization of newly nucleated microtubules at the centrosome ([@bib10]; [@bib26]; [@bib2]; [@bib31]). In mitotic *X. laevis* egg extracts, aurora A phosphorylates the kinesin-related protein Eg5, hepatoma up-regulated protein, and its coactivators, TPX2. These proteins are required for bipolar mitotic spindle assembly and can be found in a complex with XMAP215 ([@bib9]; [@bib30]). Furthermore, phosphorylation of the mitotic centromere-associated kinesin by aurora A induces its redistribution onto spindle microtubules, where it facilitates the establishment of spindle bipolarity ([@bib32]). Finally, the aster-associated protein, required for spindle assembly, is protected from degradation by the proteasome during mitosis after aurora A phosphorylation ([@bib24]; [@bib29]).

In this study, we show that aurora A can phosphorylate the p150*^glued^* component of the dynein--dynactin complex (DDC) at the microtubule-binding domain (MBD) to prevent the accumulation of dynactin and its associated protein, dynein, on the spindle microtubules.

Results and discussion
======================

Most known aurora A substrates are associated with centrosomes and spindle microtubules ([@bib1]). Thus, to identify new aurora A substrates, we decided to ask whether they could be enriched in microtubule preparations. To this end, we prepared microtubule-associated proteins (MAPs) from *Drosophila* embryos ([Fig. 1 A](#fig1){ref-type="fig"}). We used these preparations as substrates for an aurora A in vitro kinase assay (see Materials and methods). We observed a prominent labeled band of 150 kD, which was analyzed by mass spectrometry ([Fig. 1 B](#fig1){ref-type="fig"}). This protein was identified as p150*^glued^*, a subunit of the dynactin complex required for several aspects of mitosis ([@bib13]; [@bib22]; [@bib6]).

![**p150*^glued^* is an aurora A substrate in vitro.** (A) Coomassie blue--stained gel of the total embryonic extract (left) and the MAPs fraction obtained after sedimentation of taxol-polymerized microtubules (right). The strong band corresponds to the tubulins (arrowhead). (B) A kinase assay with (+) or without (−) aurora A--(His)6 was performed using 20 µg MAPs preparation. (left) The proteins were separated by SDS-PAGE and stained by Coomassie blue (CB). (right) The discrete phosphorylated band (P32) was excised and identified by mass spectrometry as p150*^glued^*. The white line indicates that intervening lanes have been spliced out. (C, left) Extracts from S2 cells stably expressing 3xFlag--aurora A were subjected to IP with preimmune (PI) or affinity-purified immune (I) anti-p150*^glued^* antibodies. (right) Extracts from wild-type S2 cells (control) or S2 cells stably expressing 3xFlag--aurora A were subjected to anti-Flag IP. The precipitates were revealed with anti-p150*^glued^* (top) or anti-Flag antibodies (bottom). Note the presence of p150*^glued^* in 3xFlag--aurora A precipitates and, conversely, the presence of aurora A in p150*^glued^* immunoprecipitates. (D) Scheme of the p150*^glued^* fusion proteins used in the kinase assay. N- and C-terminal fragments of p150*^glued^* are displayed in green and blue, respectively. (E) Recombinant MBP, MBP-Ct-Gl, and MBP-Nt-Gl were used for in vitro kinase assays using (+) or not using (−) aurora A--(His)6 protein kinase in the presence of radio-labeled γ-\[^32^P\]ATP. The position of the aurora A--(His)6 band is indicated by arrows (+). MBP and MBP-Ct-Gl, indicated by open and closed arrowheads, respectively, are not phosphorylated, whereas MBP-Nt-Gl (asterisks) is strongly phosphorylated by aurora A. The Coomassie blue--stained gel (left) and the corresponding autoradiography (right) are shown. (F) Position of the eight phosphorylated Ser residues (yellow) in the p150*^glued^* MBD (amino acids 0--200).](JCB_201001144_RGB_Fig1){#fig1}

To determine whether aurora A and dynactin might be physically associated in vivo*,* we performed immunoprecipitation (IP) experiments in *Drosophila* S2 cells stably expressing a tagged aurora A protein kinase (see Materials and methods). Endogeneous p150*^glued^* was able to pull down tagged aurora A ([Fig. 1 C](#fig1){ref-type="fig"}, left) and was found in tagged aurora A immunoprecipitates ([Fig. 1 C](#fig1){ref-type="fig"}, right), indicating the ability of aurora A and p150*^glued^* to interact in S2 cells. We wanted to check whether aurora A was able to directly phosphorylate p150*^glued^*. For this purpose, we produced recombinant N-terminal and C-terminal fragments of p150*^glued^* in fusion with the maltose-binding protein (MBP; named MBP-Nt-Gl and MBP-Ct-Gl, respectively; [Fig. 1 D](#fig1){ref-type="fig"}) in *Escherichia coli* to use in an in vitro kinase assay ([Fig. 1 E](#fig1){ref-type="fig"}). MBP alone and MBP-Ct-Gl were not phosphorylated by aurora A in vitro, whereas MBP-Nt-Gl was a good substrate. Phosphomapping by mass spectrometry revealed phosphorylation of eight Ser residues (Ser85, -109, -117, -135, -137, -138, -144, and -183) within a 200--amino acid N-terminal domain corresponding to the MBD ([Fig. 1 F](#fig1){ref-type="fig"}). Most of these sites (except Ser137 and Ser138) matched the yeast and mammalian aurora phosphorylation known consensus site RXS/TΦ (where Φ is a hydrophobic residue; [@bib3]; [@bib7]). These phosphorylated sites were also detected with other sites after proteomic analyses of p150*^glued^* isolated from Kc *Drosophila* cultured cells in vivo (<http://www.sbeams.org/dev1/sbeams/cgi/Glycopeptide//peptideSearch.cgi>). A purified recombinant MBD in which all phosphorylated Sers were mutated into Alas had lost its ability to be phosphorylated by aurora A in vitro ([Fig. 2 A](#fig2){ref-type="fig"}). Interestingly, these sites contribute to ∼60% of total MBD phosphorylation by S2 cell extracts, confirming that other phosphorylation sites exist on p150*^glued^* MBD in vivo ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1)). Furthermore, phosphorylation assays using an aurora A--depleted extract showed that aurora A by itself contributes to ∼25% of total MBD phosphorylation observed in S2 cells (Fig. S1 B). p150*^glued^* MBD is responsible for the microtubule-binding properties of dynactin, and its deletion affects mitotic but not interphase functions of the protein ([@bib19]). To analyze the relevance of those phosphorylation events in vivo, we examined the consequences of expressing either a GFP-tagged wild-type (MBD-GFP) or nonphosphorylatable variant of the p150*^glued^* MBD (MBD-SA8-GFP) in S2 cells ([Fig. 2 B](#fig2){ref-type="fig"}). We established stable cell lines in which such constructs were expressed at equivalent levels ([Fig. 2 C](#fig2){ref-type="fig"}). By immunostaining, both proteins were able to bind microtubules during interphase when aurora A was not active ([Fig. 2 D](#fig2){ref-type="fig"}). During early mitosis, MBD-GFP and MBD-SA8-GFP were strongly associated with centrosomal microtubules. However, the nonphosphorylatable MBD-SA8-GFP mutant protein was retained on the spindle microtubules during mitosis in all cells examined during metaphase but not MBD-GFP (*n* \> 200; [Fig. 2](#fig2){ref-type="fig"}, compare E \[middle\] with F \[middle\]). We assessed the binding of recombinant MBD and MBD-SA8 to taxol-polymerized microtubules in vitro. The p150*^glued^* MBD affinity for microtubules was five times weaker after incubation with aurora A protein kinase and ATP. In these conditions, we found that the mutagenesis of the eight Sers into Alas restored the ability of p150*^glued^* MBD to bind to the microtubules (Fig. S1 C). Thus, the direct interaction of the p150*^glued^* MBD with the microtubules appears to be negatively regulated by aurora A phosphorylation in vitro and in vivo during mitosis.

![**The MBD of p150*^glued^* is phosphorylated by aurora A after nuclear envelope breakdown.** (A) Wild-type (WT) or mutant MBD fragment in which the eight Sers (phosphorylated by aurora A) were mutated into Alas (MBD-SA8) were subjected to a kinase assay in the presence of active (AUR A WT) or inactive (AUR A K/R) recombinant aurora A kinase. The Coomassie blue (CB)--stained gel (top) was subjected to autoradiography (bottom). The p150*^glued^* MBD fragment (closed arrowhead) is strongly phosphorylated in the presence of active (but not inactive) aurora A protein kinase, whereas the MBD-SA8 fragment (open arrowhead) remains unphosphorylated. (B) Scheme of the wild-type (MBD-GFP) or mutant (MBD-SA8-GFP) proteins stably expressed in S2-cultured cells. (C) Control (cont) or S2 cell extracts expressing MBD-GFP or MBD-SA8-GFP were separated by SDS-PAGE, transferred onto a nitrocellulose membrane, and stained by Ponceau S as a loading control (left). The membrane was blotted for p150*^glued^*. The position of the ∼50-kD MBD-GFP and MBD-SA8-GFP proteins is indicated (arrowhead). (D--F) Interphase S2 cells expressing MBD-GFP (top) or MBD-SA8-GFP (bottom) were fixed and stained for tubulin (red; middle in monochrome) or GFP (green; right in monochrome). Both GFP fusions associate with the interphase microtubule network. S2 cells expressing either MBD-GFP (E) or MBD-SA8-GFP (F) were methanol fixed and stained for DNA (blue), tubulin (red; middle in monochrome), and GFP (green; bottom in monochrome). During prophase, the GFP signal was strong at the centrosome region for both proteins. Unlike MBD-GFP, the mutant MBD-SA8-GFP protein remains strongly associated with spindle microtubules during all mitotic steps. Bars, 10 µm.](JCB_201001144_RGB_Fig2){#fig2}

As p150*^glued^* MBD is required for mitotic spindle assembly ([@bib19]), it was tempting to speculate that phosphorylation at the sites we have mapped is required to control the overall dynactin accumulation on the mitotic spindle. To test this hypothesis, we checked whether a full-length p150*^glued^* GFP fusion protein in which the eight aurora A phosphorylation sites (Sers) had been replaced by Alas (p150-SA8-GFP) would (a) accumulate on spindle microtubules and (b) be able to complement p150*^glued^* depletion. For this purpose, we induced the expression of either the GFP-tagged p150*^glued^* wild-type protein (p150-GFP) or a mutant variant (p150-SA8-GFP; [Fig. 3 A](#fig3){ref-type="fig"}). After several hours of induction of their metallothionein promoter with copper, both GFP-fused proteins were detected by Western blot analysis ([Fig. 3 B](#fig3){ref-type="fig"}). Using a double-stranded RNA (dsRNA) specific to the *glued* 3′UTR gene ([Fig. 3 A](#fig3){ref-type="fig"}; [@bib19]), we were able to deplete the endogenous p150*^glued^* but not the exogenous GFP-tagged protein ([Fig. 3 C](#fig3){ref-type="fig"}). In addition, sucrose gradient separation analyses revealed that both GFP fusion proteins were sedimenting together with endogenous p150*^glued^* in the 19S dynactin complex ([Fig. 3 D](#fig3){ref-type="fig"}). As reported previously in S2 cells, p150*^glued^*-depleted mitotic cells showed an obvious disconnection of centrosomes from the mitotic spindle in 67.3 ± 11.6% of the metaphase cells ([Fig. 3 E](#fig3){ref-type="fig"}, compare left with right), whereas only 22.4 ± 4% of the cells showed this phenotype in control cells ([@bib13]; [@bib15]; [@bib25]). Interestingly, we completely rescued this defect by expression of p150-GFP (26.7 ± 12%) but not p150-SA8-GFP (69.6 ± 6.9%; [Fig. 3 E](#fig3){ref-type="fig"}). In addition to that, the wild-type protein was weakly localized on spindle microtubules compared with the mutant, which showed strong association with these microtubules ([Fig. 3 F](#fig3){ref-type="fig"}). This localization of p150-GFP and p150-SA8-GFP was confirmed by high resolution time-lapse video microscopy. As seen in [Fig. 4](#fig4){ref-type="fig"} (left; and [Video 1](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1)), the p150-GFP protein weakly localized on the spindle region and microtubule plus ends ([Fig. 4](#fig4){ref-type="fig"}, triangles), whereas p150-SA8-GFP strongly decorated mitotic spindle fibers and microtubule plus ends ([Fig. 4](#fig4){ref-type="fig"}, right; and [Video 2](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1)). The kinetochore localization ([Fig. 4](#fig4){ref-type="fig"}, arrows) remained identical for both constructs. All of these results led us to investigate whether aurora A was responsible for the dynamics of dynactin during mitosis. To do so, we generated a new p150*^glued^* antibody against the C-terminal fragment of p150*^glued^* ([Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1)) to localize the p150*^glued^* protein during mitosis in *Drosophila* S2-cultured cells. Using this antibody, we observed a staining of the centrosomal microtubules during prophase and the early stages of spindle formation. The signal decreased during spindle maturation before becoming enriched once more at telophase, suggesting that spindle pole localization of p150*^glued^* was inhibited after nuclear envelope breakdown ([Fig. 5 A](#fig5){ref-type="fig"}). We also found a transient staining of the kinetochore regions of chromosomes during prometaphase that was replaced after chromosome congression by a weak staining of spindle fibers, which is similar to the findings of others ([@bib25]). After *aurora A* RNAi, 60% of the metaphase cells (*n* = 3; 200 cells) showed stronger staining of the spindle pole regions ([Fig. 5 A](#fig5){ref-type="fig"}, arrows; and [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1)). Interestingly, identical results were obtained after aurora A knockdown in human HeLa cells (unpublished data), suggesting that DDC regulation is conserved from *Drosophila* to humans. We further showed the same behavior for the dynactin-interacting protein dynein, which accumulated at the spindle poles after *aurora A* RNAi in S2-cultured cells (Fig. S2 B). We also asked whether dynactin could become mislocalized in larval neuroblasts from *aurora A* mutants. As previously described ([@bib25]), dynactin was faintly distributed along the spindle fibers of wild-type cells in metaphase. In contrast, ∼60% of the *aurora A* mutant cells with a bipolar spindle showed an accumulation of dynactin in the spindle pole regions or all over the spindle (six brains; 60 metaphase cells; [Fig. 5 B](#fig5){ref-type="fig"}, arrowheads). In these mutant cells, dynein strikingly followed the same behavior (*n* = 3; 35 metaphase cells; Fig. S2 C). Together, these data strongly suggest that aurora A participates in the control of the dynactin binding to microtubules, which is an event required for DDC function.

![**A full-length p150*^glued^* that can no longer be phosphorylated by aurora A binds more strongly to microtubules but cannot rescue *glued* spindle assembly defect.** (A) Scheme of the GFP fusion proteins expressed in S2 cell lines under the control of the metallothionein promoter (inducible by Cu^2+^). The constructs lack the *glued* gene 3′UTR (top) targeted by RNAi. (B) p150*^glued^* (top) or actin (bottom) Western blot showing p150-GFP (left) and p150-SA8-GFP (right) protein levels after 0 and 18 h induction on the corresponding cell line. (C) p150*^glued^*, p150-GFP, p150-SA8-GFP, and actin protein levels after *glued* 3′UTR RNAi (lanes 2 and 3). Note the knockdown of endogenous p150*^glued^*, whereas p150-GFP protein level remains stable. (D) p150*^glued^* Western blot analysis of the different sucrose fractions after the sedimentation assay (from 5 to 40%) of S2 cell extracts expressing either p150-GFP (top) or p150-SA8-GFP (bottom). (E, left) Fixed control or p150*^glued^*-depleted metaphase cells are stained for DNA in blue, microtubules in red (monochrome in bottom), and centrosomes in green. The arrows point to disconnected centrosomes. (E, right) Quantification of the centrosome disconnection phenotype in control or *glued* 3′UTR dsRNA-treated S2-cultured cells. Note the rescue obtained after induced expression of p150-GFP protein but not p150-SA8-GFP. (F) Spindle morphology in p150*^glued^* cells after p150-GFP (top) or p150-SA8-GFP (bottom) expression. DNA (blue), microtubules (red; monochrome in the third column), centrosomes (green), and GFP (green in merge; monochrome on the right) are displayed. p150-SA8-GFP interacts more strongly with spindle microtubules than its wild-type counterpart. The arrows point out the disconnected centrosomes. Error bars indicate mean ± SD. Bars, 10 µm.](JCB_201001144_RGB_Fig3){#fig3}

![**p150-SA8-GFP displays higher affinity for microtubules than wild-type p150-GFP protein during mitosis.** S2 cells expressing equivalent levels of p150-GFP (left) or p150-SA8-GFP (right) were imaged by time-lapse video microscopy ([Videos 1](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1) and [2](http://www.jcb.org/cgi/content/full/jcb.201001144/DC1)). The p150-SA8-GFP protein is strongly associated with spindle fibers and microtubule plus ends, whereas p150-GFP shows moderate association with these structures (arrowheads). The kinetochore localization (arrows) is not affected. Bar, 10 µM.](JCB_201001144_RGB_Fig4){#fig4}

![**p150^*glued*^ accumulates at spindle poles of *aurora A* RNAi-deficient S2 cells and *aurora A* mutant neuroblasts.** (A) Control S2 cells (top) were fixed and stained for tubulin (red), p150^*glued*^ (green), and DNA (blue). The mitotic phases are displayed at the top. p150^*glued*^ localization at spindle poles is clearly detected during prophase and cytokinesis, whereas the signal is very weak during prometaphase and metaphase. In parallel, ∼60% of *aurora A--*depleted cells (bottom) exhibit p150*^glued^* accumulation at spindle poles (arrows). (B) Wild-type (left) or *aurora A^e209^*/Df(3R)T61 (right) mutant neuroblasts were fixed and stained for tubulin (green; monochrome in middle), p150*^glued^* (red; monochrome in bottom), and DNA (blue). In control metaphase cells, p150*^glued^* is faintly detected along spindle fibers. In *aurora A* mutant neuroblasts, p150*^glued^* accumulates on spindle fibers and spindle poles (arrowheads). Bars, 10 µm.](JCB_201001144_RGB_Fig5){#fig5}

The dynactin complex, composed of p150*^glued^* and at least 10 other polypeptides, cooperates with dynein to fulfill multiple roles during mitotic progression ([@bib18]; [@bib13]; [@bib22]; [@bib6]). In *Drosophila* S2 cells, DDC is required for the centrosome connection to the mitotic spindle and for the metaphase/anaphase transition ([@bib13]; [@bib22]). Our RNAi experiments in S2 cells confirm these previous studies, as centrosomes were disconnected from the poles in ∼70% of the p150*^glued^*-depleted mitotic cells. Both RNAi experiments and mathematical models concur in the notion that kinetochore fibers are captured and focused at the poles by the DDC, which connects these fibers to the centrosome-nucleated microtubules. Thus, a lack of DDC can explain the fact that centrosomes are disconnected from the spindle ([@bib20]; [@bib14]). Our study revealed that aurora A participates in the phosphoregulation of p150*^glued^*, but other kinases can contribute to this process on p150*^glued^* MBD itself (Fig. S1) or other DDC subunits ([@bib17]; [@bib27], [@bib28]). Interestingly, the variant that can no longer be phosphorylated by aurora A remains associated with spindle microtubules and cannot complement the *glued* loss of function. This suggests that DDC levels on spindle microtubules and at the poles need to be tightly controlled in *Drosophila* cells to avoid centrosome disconnection, a phenotype sometimes also observed in *aurora A* mutant embryos (unpublished data), but not in other cell types in which other kinases possibly participate in dynactin limitation. The reason why DDC localization at spindle poles needs to be modulated remains unclear. It is possible that DDC function requires a moderate association of dynactin with spindle microtubules. It is also possible that overaccumulation of DDC (and cargoes) could create a traffic obstruction at spindle poles to compete with other MAPs. Consequently, this would prevent the connection between kinetochore fibers and astral microtubules. Further studies will be required to elucidate the complete DDC regulation during mitosis.

Materials and methods
=====================

Preparation of microtubules from *Drosophila* embryos for aurora A phosphorylation assays
-----------------------------------------------------------------------------------------

500 µl *Drosophila* early embryos (0--4 h) were collected and lysed in 500 µl BRB80 buffer (80 mM Pipes, pH 6.8, 1 mM MgCl~2~, and 1 mM EGTA) supplemented with protease inhibitors (Roche) and 0.5% NP-40. The crude extract was centrifuged at 10,000 *g* for 15 min at 4°C. The supernatant was centrifuged a second time at 100,000 *g* for 20 min at 4°C. 0.4 ml supernatant containing the soluble proteins was supplemented with 20 µM taxol and 1 mM GTP. Microtubule polymerization was induced for 20 min at 25°C. The microtubules were sedimented on a 0.4 ml BRB80 cushion supplemented with 20 µM taxol, 1 mM GTP, and 40% glycerol. The microtubule pellet containing the MAPs was washed twice in BRB80 and resuspended in BRB80. The MAP fractions were stored at −80°C.

Phosphorylation assay
---------------------

20 µg MAPs fraction or 3 µg recombinant substrate proteins was incubated with 200 ng recombinant aurora A--(His)6 kinase, 1 µCi radio-labeled γ-\[^32^P\]ATP (GE Healthcare), and 100 µM ATP in kinase buffer ([@bib10]).

The samples were separated by SDS-PAGE and stained by Coomassie blue. p150*^glued^* was identified by mass spectrometry on the excised band from the gel. To map the phosphorylation sites on the MBP-Nt-Gl protein, the kinase assay was performed without radio-labeled ATP, and the phosphorylated band was excised and sent for phosphopeptide identification to the Proteomic Platform of the Quebec Genomic Center (<http://proteomique.crchul.ulaval.ca/en/equipment.html>).

For in vivo phosphorylation assay, 3 × 10^6^ control or aurora A--depleted cells were resuspended in 500 µl of lysis buffer containing protease inhibitors (10 mM Na~2~VO~4~ and 50 mM β-glycerophosphate; [@bib10]). 5 µl of the extract was used to phosphorylate 5 µg MBD or MBD-SA8 in the presence of 2.5 µCi radio-labeled γ-\[^32^P\]ATP (GE Healthcare) and 100 µM cold ATP in kinase buffer. MBD and MBD-SA8 phosphorylation signals were quantified using a phosphoimager (Molecular Dynamics).

dsRNA production and constructs
-------------------------------

The *aurora A* dsRNA production was described previously ([@bib8]; [@bib10]). In brief, an ∼1,000-bp PCR product containing a T7 sequence at each end was used as a template to generate RNA using the Megascript kit (Promega). To obtain the *glued* template (for the 3′UTR region), an ∼450-bp PCR product using the primers 5′-AATAATACGA­CTCACTATAGG­GAAAGGATCDT­GTATCGTGGCA-3′ and 5′-AATAATACGA­CTCACTATAGG­GGAGTTATACA­ACATCAGCAAA-3′ was produced. After isolation, the RNAs were boiled for 20 min and annealed by slow cooling overnight at room temperature. dsRNAs were analyzed by agarose gel electrophoresis and aliquoted at −80°C before use in RNAi experiments. To generate the expression construct encoding the full-length aurora A in fusion with 3xFlag at its N-terminal end, *aurora A* ORF was first cloned into the pENTR vector (to create an entry clone) using a cloning kit (TOPO; Invitrogen) and recombined using the gateway system (Invitrogen) into the pHFW containing the 3xFlag tag and a heat shock promoter. An aurora A kinase-dead mutant (K193/R) was generated by mutation of the conserved lysine of the kinase subdomain II into an arginine.

For the MBD expression constructs, each Ser to Ala mutation in the p150*^glued^* MBD was obtained by sequential PCRs. The wild-type (MBD) or nonphosphorylatable (MBD-SA8) domains were cloned directly into pET102/TOPO bacterial expression vector or pENTR to generate entry clones. The latter clones were recombined into pDEST17 to generate bacterial expression constructs and in pAWG to allow S2 cell expression of either MBD-GFP or MBD-SA8-GFP under the control of the actin 5c promoter. Both pAWG and pHFW were obtained from the Carnegie Institution of Washington.

N- and C-terminus domains of p150*^glued^* were amplified by PCR and cloned into the pMal-C2E expression vector using KpnI and BamHI restriction sites. All constructs were verified by sequencing.

Full-length p150*^glued^* was cloned into pMT-GFP-Ct (provided by M. Savoian, University of Cambridge, Cambridge, England, UK) using the gateway system (through an entry clone) to generate p150-GFP expression construct. p150-SA8-GFP was subsequently obtained with the QuickChange Mutagenesis kit (Agilent Technologies). The pAct5C-Cherry--α-tubulin construct was provided by G. Hickson (University of California, San Francisco, San Francisco, CA).

Production of the recombinant proteins and antibody purification
----------------------------------------------------------------

Aurora A--(His)6, aurora A--K/R-(His)6, MBD-(His)6, or MBD-SA8-(His)6 were purified as described previously ([@bib10]). MBP-Nt-Gl and MPB-Ct-Gl were expressed in *E. coli* BL21(DE3) pLysS (EMD) for 4 h at 25°C, purified on an amylose column, and dialysed against PBS and stored at −80°C before use for aurora A kinase assay. The purified MBP-Ct-Gl protein was also used to immunize rabbits. Obtained anti-p150*^glued^* antibodies were affinity purified on a nitrocellulose membrane, and the purified antibodies were stored at −80°C as described previously ([@bib21]).

In vitro microtubule-binding assay
----------------------------------

1 µg purified recombinant p150*^glued^* MBD or MBD-SA8 proteins in fusion with a hexahistidine tag was incubated with either 200 ng aurora A or aurora A--K/R proteins in kinase buffer containing 1 mM ATP in a total volume of 10 µl for 20 min. The kinase reaction was then incubated with 25 µl (100 µg) of taxol-stabilized microtubules for 10 min at 37°C ([@bib23]). The microtubule pellet and the supernatant containing microtubule-unbound proteins were separated by sedimentation at 100,000 *g* for 20 min at 37°C (TLA-100; Beckman Coulter). The proteins present in the pellets and supernatants were analyzed by Western blotting or Coomassie blue staining.

RNAi, transfections, drug treatment, stable line generation, and rescue experiments
-----------------------------------------------------------------------------------

*Drosophila* S2 cells were grown and processed for RNAi as described previously ([@bib4]). In brief, 10^6^ cells were incubated with 10 µg/ml dsRNA in media without serum. Alternatively, 10 µg transfection reagent (Transfast; Promega) was added together with 3 µg dsRNA following the manufacturer\'s instructions. After 1 h, fresh media were added to the cells. At 4 d after transfection, the cells were fixed and analyzed for mitotic defects ([@bib8]). 100--200 mitoses were scored and analyzed per experiment, and each experiment was repeated at least three times.

To make S2 stable lines expressing 3xFlag--aurora A, MBD-GFP or MBD-SA8-GFP, p150-GFP, and p150-SA8-GFP, 5 µg of each expression construct was cotransfected with 1 µg pIB/V5-His/CAT (Invitrogen). Alternatively, 5 µg pAct5c-Cherry--α-tubulin was cotransfected in those cells. Transfection reagent (Effectene; QIAGEN) was used for transfection. Stable lines were selected and expanded in media containing 25 µg/ml blasticidin S (Invitrogen). For rescue experiments, expression of either p150-GFP or p150-SA8-GFP proteins was induced 18 h before fixation by supplementing media with CuSO~4~ (300 µM final concentration).

Immunofluorescence analysis
---------------------------

S2 cells were fixed in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, and 4 mM MgCl~2~) containing 3.7% formaldehyde and 0.1% Triton X-100. In some cases, the cells were plated on concanavalin A--coated coverslips for 1 h and fixed in methanol at −20°C for 10 min. The fixed cells were briefly washed in PBS and blocked for 1 h in PBS containing 0.1% Triton X-100 and 1% BSA (PBST-BSA). Primary antibodies were incubated overnight at 4°C, and secondary antibodies were incubated for 1 h at room temperature in PBST-BSA. DNA was stained with Hoechst 33258. Slides were mounted in ProLong gold (Invitrogen) and observed with a microscope (DMRXA2; Leica) using a 63× 1.3 NA objective. Images were acquired with a camera (CoolSnap HQ; Photometrics) and processed with MetaMorph software (Universal Imaging). Alternatively, images were acquired with an inverted confocal microscope (SP2; Leica).

Time-lapse imaging
------------------

S2 cells expressing p150-GFP or p150-SA8-GFP were incubated with CuSO~4~ (300 µM final concentration) for 18 h and plated for 1 h on concanavalin A--coated incubation chambers (Labtek; Sigmatek) before imaging. Images were aquired using a spinning-disk system mounted on an inverted microscope (Elipse Ti; Nikon) using a 100× 1.4 NA objective. Images were acquired every 5 or 10 s with a camera (CoolSnap HQ2; Photometrics) controlled by the MetaMorph acquisition software.

Antibodies and Western blotting
-------------------------------

The YL1/2 rat anti-tyrosinated tubulin antibody (1:1,000) was obtained from Millipore, and the GTU-88 mouse anti--γ-tubulin antibody (1:1,000) was obtained from Sigma-Aldrich. The mouse anti-dynein clone 1H4 antibody (1:100) was provided by T. Hays, and the anti-GFP monoclonal antibodies (1:1,000) were obtained from Roche or Invitrogen. Affinity-purified antibodies against aurora A were used at 0.5 µg/ml ([@bib10]). The affinity-purified anti-p150*^glued^* antibody was purified as described previously ([@bib21]) and used at 2 µg/ml. Secondary peroxidase-conjugated antibodies were obtained from Jackson ImmunoResearch Laboratories, Inc., and Alexa Fluor--conjugated secondary antibodies were obtained from Invitrogen. For Western blotting, ECL reagent was purchased from Thermo Fisher Scientific.

Online supplemental material
----------------------------

Fig. S1 shows the contribution of aurora A and other unknown kinases to p150*^glued^* MBD phosphorylation in vivo. It also shows that aurora A kinase inhibits MBD binding to microtubules in vitro. Fig. S2 shows p150*^glued^* antibody Western blotting in control or aurora A--depleted cells together with dynein localization in control or aurora A--depleted S2 cells. The colocalization of dynein and dynactin is also displayed in wild-type or *aurora A* mutant neuroblasts. Fig. S3 shows the distribution (line scans) of p150*^glued^* and tubulin in control or aurora A--depleted cells. Videos 1 and 2 show the behavior of wild-type and nonphosphorylatable p150*^glued^* proteins fused to GFP during metaphase. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201001144/DC1>.
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